China CDC Issues Ebola Alert After WHO Declares Emergency
The Chinese Center for Disease Control and Prevention (China CDC) issued a formal prevention notice on May 23, 2026, urging heightened vigilance against Ebola virus disease following the World Health Organization’s declaration that the outbreak in the Democratic Republic of the Congo (DRC) and Uganda constitutes a Public Health Emergency of International Concern (PHEIC). The notice, published via the agency’s official WeChat account and reported by CCTV News, outlines key measures for travelers, medical institutions, and the general public.
Context: The DRC Ebola Outbreak
On May 5, 2026, the WHO was alerted to an outbreak of an unknown disease with high mortality in the Mongbwalu health zone of Ituri Province, eastern DRC. By May 15, the National Institute of Biomedical Research in Kinshasa confirmed the presence of Bundibugyo virus (BDBV), a species of Ebola virus distinct from the more common Zaire ebolavirus. The DRC Ministry of Health declared the country’s 17th Ebola outbreak since 1976.
On May 17, WHO Director-General Dr. Tedros Adhanom Ghebreyesus declared the epidemic a PHEIC, noting that the event “does not meet the criteria of a pandemic emergency” but warning of “significant local and regional risk of spread.” The Africa CDC declared the outbreak a Continental Public Health Emergency the following day.
China’s Preventive Measures
The China CDC notice, issued in coordination with the General Administration of Customs (GAC), specifies three key measures:
First, travelers arriving from affected regions — including the DRC and Uganda — must undergo 21-day self-health monitoring from the date of entry, aligning with the maximum incubation period for Ebola virus disease. If symptoms such as fever, fatigue, headache, sore throat, vomiting, diarrhea, or unexplained bleeding occur, individuals are instructed to contact local CDC authorities or community health centers by phone before seeking medical care.
Second, all medical institutions are required to proactively inquire about overseas travel history and exposure contacts when treating patients with Ebola-compatible symptoms. Any travelers returning from affected regions must be promptly reported to hospital public health departments and district CDC authorities.
Third, the notice advises the public to monitor WHO updates as the outbreak evolves, noting that the list of affected countries and regions may change.
The Bundibugyo Virus Challenge
A critical concern highlighted by health authorities is that the outbreak is caused by the Bundibugyo virus species, for which no approved vaccines or specific therapeutics currently exist. This stands in stark contrast to the Zaire ebolavirus, for which vaccines like Ervebo and treatments like Inmazeb are available. The Africa CDC noted it is monitoring three candidate vaccines for Bundibugyo virus and working to accelerate research and evaluation.
As of May 22, the Africa CDC reported 745 suspected cases and 83 confirmed cases in the DRC, with 176 suspected deaths and 8 confirmed deaths. Uganda reported 2 imported confirmed cases (1 death) initially, and on May 23 reported 3 new local cases — the first evidence of local transmission. At least four healthcare worker deaths have been reported, raising concerns about infection control gaps.
International Response
On May 23, the Africa CDC and WHO jointly released a 6-month preparedness and response plan with a total budget of $319 million, covering all 55 African Union member states. Ten high-risk countries were identified: South Sudan, Rwanda, Kenya, Zambia, Central African Republic, Tanzania, Ethiopia, Angola, Republic of Congo, and Burundi.
The WHO has explicitly advised against border closures or travel restrictions, stating such measures “have no basis in science” and can push movement to unmonitored informal crossings. China’s approach — enhanced monitoring for incoming travelers without imposing a travel ban — represents a calibrated middle ground.
What to Watch For
The coming weeks will be critical in determining whether the outbreak can be contained. Key factors include the effectiveness of community engagement in affected areas of eastern DRC, where community resistance and rumors have previously hampered response efforts. The development of candidate vaccines for Bundibugyo virus remains a priority, as does the monitoring of Uganda’s newly reported local transmission cases. China’s proactive issuance of prevention guidelines reflects lessons learned from previous global health emergencies and underscores the importance of international coordination in responding to emerging infectious disease threats.